Factors Affecting The Diagnosis And Treatment Of Non-STEMI Patients Who Were Suspected To Have COVID-19
Research Article
DOI:
https://doi.org/10.5281/zenodo.7884207Keywords:
COVID-19, non-STEMI, Mortality.Abstract
Introduction and Objective: In this study, it was aimed to analyze the factors affecting the management of patients with suspected COVID-19 who applied to the emergency department with chest pain and were diagnosed with non-STEMI.
Method: A total of 69 patients who applied to Sakarya Training and Research Hospital between 01/05/2020 – 30/04/2021 and were diagnosed with non-STEMI with a suspicion of COVID-19 have been analyzed retrospectively. The demographic characteristics (age, gender), comorbid diseases, laboratory parameters (hemogram, biochemistry and serological test results), thorax computerized tomography (CT) findings (consistent or incompatible with COVID-19), angiography results, intervention requirements and mortality status were recorded. The diagnosis of COVID-19 has been confirmed via positive RT-PCR test.
Results: When laboratory parameters were compared according to CT results, NLR, CRP and Ferritin values were statistically higher in patients with a CT image compatible with COVID-19 (p=0.026, p=0.002, p<0.001). The CRP result of the patients with a COVID-19 compatible CT imaging and positive RT-PCR result was statistically significantly higher than the control group (p=0.040). When the laboratory parameters of the patients were compared according to the RT-PCR results, the PLR and CRP values of the patients with positive RT- PCR were statistically significantly higher (p=0.027, p=0.001, respectively). It was determined that patients with statistically low NLR, PLR and CRP values (p=0.046, p=0.023, p=0.005) and patients with statistically significantly high lymphocyte and troponin values required Coronary Angiography intervention (p=0.013, p=0.001). In addition, it was determined that patients whose CT was not compatible with COVID-19 and whose RT-PCR test was negative required more Coronary Angiography intervention (p=0.004, p=0.003, respectively).
Conclusion: PLR and CRP values can be used in the differential diagnosis in the presence of suspected COVID-19 in patients who present to the emergency department with chest pain and are diagnosed with non-STEMI.
References
Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev. 2021;26(1):1-10. doi:10.1007/s10741-020-10008-2
Salabei JK, Asnake ZT, Ismail ZH, Charles et al. COVID-19 and the cardiovascular system: an update. Am J Med Sci. 2022;364(2):139-147. doi:10.1016/j.amjms.2022.01.022
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
Xiang D, Xiang X, Zhang W, et al. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China. J Am Coll Cardiol. 2020;76(11):1318- 1324. doi:10.1016/j.jacc.2020.06.039
De Rosa S, Spaccarotella C, Basso C, et al. Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083-2088. doi:10.1093/eurheartj/ehaa409
Gao J, Lu PJ, Li CP, et al. Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic. BMC Cardiovasc Disord. 2022;22(1):194. doi:10.1186/s12872-022-02626-5
Liao CT, Chang WT, Yu WL, Toh HS. Management of acute cardiovascular events in patients with COVID-19. Rev Cardiovasc Med. 2020;21(4):577-581. doi:10.31083/j.rcm.2020.04.140
Choi H, Lee JH, Park HK, et al. Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction. J Korean Med Sci. 2022;37(21):e167. doi:10.3346/jkms.2022.37.e167
De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI. J Am Coll Cardiol. 2020;76(20):2321-2330. doi:10.1016/j.jacc.2020.09.546
De Luca G, Cercek M, Jensen LO, et al. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry. Cardiovasc Diabetol. 2020;19(1):215. Published 2020 Dec 18. doi:10.1186/s12933-020-01196-0
Nai Fovino L, Cademartiri F, Tarantini G. Subclinical coronary artery disease in COVID-19 patients. Eur Heart J Cardiovasc Imaging. 2020;21(9):1055-1056. doi:10.1093/ehjci/jeaa202
Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130-136. doi:10.1097/MCA.0000000000000768
Liu J, Ao W, Zhou J, Luo P, Wang Q, Xiang D. The correlation between PLR-NLR and prognosis in acute myocardial infarction. Am J Transl Res. 2021;13(5):4892- 4899.
Li L, Ma Y, Geng XB, et al. Platelet-to- lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction. Aging Clin Exp Res. 2021;33(3):619-624. doi:10.1007/s40520-020- 01555-7.
Meng Z, Yang J, Wu J, Zheng X, Zhao Y, He Y. Association between the platelet- lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction. Clin Cardiol. 2021;44(7):994-1001. doi:10.1002/clc.23648
Willim HA, Harianto JC, Cipta H. Platelet-to-Lymphocyte Ratio at Admission as a Predictor of In-Hospital and Long-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Cardiol Res. 2021;12(2):109-116. doi:10.14740/cr1219
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3
Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014-1015. doi:10.1016/S0140-6736(20)30633-4
Zhang J, Wang Z, Wang X, Hu Z, Yang C, Lei P. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case- Control Study. Front Immunol. 2021;12:581469. doi:10.3389/fimmu.2021.581469
American College of Cardiology. Troponin and BNP Use in COVID-19.
https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnpuse-incovid19?utm_source=accupdate&utm_medium=email_newsletter&utm_content=20200320&utm_campaign=accupdate. (Accessed Mar 23, 2020.)
Majeed H, Gangu K, Sagheer S, et al. COVID-19 and NSTEMI Outcomes among Hospitalized Patients in the United States and Racial Disparities in Mortality: Insight from National Inpatient Sample Database. Vaccines 2022;10:2024. doi:10.3390/vaccines10122024
Salabei JK, Asnake ZT, Ismail ZH, et al. COVID-19 andthecardiovascularsystem: an update. Am J MedSci. 2022;364(2):139-147. doi:10.1016/j.amjms.2022.01.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Medica Ruha
This work is licensed under a Creative Commons Attribution 4.0 International License.
